abstract |
The present invention relates to a herpes zoster vaccine composition, which comprises a glycoprotein E, a glucopyranosyl lipid adjuvant, and a metabolic oil of Varicella zoster virus, and is capable of selecting a cell mediated immune response without the disadvantages of an attenuated live vaccine To a herpes zoster vaccine composition which is high in safety and excellent in herpes zoster prevention effect. |